Skip to main content

Table 4 Spearman correlation analysis of AGEs and other indicators

From: Correlation between the accumulation of skin glycosylation end products and the development of type 2 diabetic peripheral neuropathy

Indicators

rs

P

CVD risk score

.831**

.000

DPN risk score

.756**

.000

DR risk score

.813**

.000

DN risk score

.818**

.000

TG

−.040

.346

HDL-C

.039

.366

Cr

.395**

.000

CysC

.381**

.000

Hcy

.232**

.000

ACR

.179**

.003

eGFR

−.434**

.000

MAU

.248**

.000

α-MG

.354**

.000

Tf

.303**

.000

Ig

.257**

.000

NEUT

.221**

.000

LY

−.117**

.006

NLR

.248**

.000

CRP

.143**

.001

HOMAIR

−.313**

.006

PFG

.037

.398

FINS

−.241*

.035

C-Peptide

−.022

.727

2hC-Peptide

−.086

.167

HbA1c

.003

.945

TCSS score

.454**

.000

  1. ** Significant correlation at .01 level; * significantly correlated at the .05 level